Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Universitario La Paz (2)

2023

  1. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A

    Signal Transduction and Targeted Therapy, Vol. 8, Núm. 1

2019

  1. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer, Vol. 29, Núm. 7, pp. 1141-1147